Stock comparison
Camurus AB (publ)
CAMX.ST$36.93BHealthcare Market cap, Sector
Pfizer
PFE$142.14BHealthcare Market cap, Sector
Overall winner
Camurus AB (publ)
CAMX.ST 70 PFE
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
CAMX.ST7wins
0winsPFE
78B
D49
91A
D48
94A
F41
65C
F16
63C
F25
77B
D52
77B
D48
Side-by-side metrics
| Metric | CAMX.ST | PFE |
|---|---|---|
| Market cap | $36.93B | $142.14B Winner |
| P/E (TTM) | 42.6x | 19.9x Winner |
| EV/EBIT | 29.5x | 13.7x Winner |
| ROIC (TTM) | Winner: 17.17% | 7.97% |
| Gross margin | Winner: 93.11% | 69.35% |
| Net margin | Winner: 32.47% | 11.83% |
| Revenue CAGR 5y | Winner: 33.3% | -6.33% |
| EPS CAGR 5y | Winner: 132.79% | -23.42% |
| Debt / Equity | Winner: 0.0x | 0.7x |
| Dividend yield | - | 6.58% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CAMX.ST leads on
- Revenue CAGR 5y33.3%vs -6.33%+119%
- EPS CAGR 5y132.79%vs -23.42%+118%
- Debt / Equity0.0xvs 0.7x+97%
- Net margin32.47%vs 11.83%+64%
PFE leads on
- Market cap$142.14Bvs $36.93B+74%
- EV/EBIT13.7xvs 29.5x+54%
- P/E (TTM)19.9xvs 42.6x+53%
More like CAMX.ST
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.